Covenant Partners, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covenant Partners, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$619,033
-2.4%
40,015
-0.9%
0.22%
-1.7%
Q2 2023$634,417
-12.0%
40,383
-7.7%
0.23%
-17.0%
Q1 2023$720,835
+0.2%
43,740
-5.1%
0.28%
-4.5%
Q4 2022$719,191
+26.8%
46,102
+5.4%
0.29%
+4.7%
Q3 2022$567,000
-16.6%
43,740
-9.7%
0.28%
-12.4%
Q2 2022$680,000
-2.0%
48,4620.0%0.32%
+13.7%
Q1 2022$694,000
+16.4%
48,462
+10.8%
0.28%
+25.3%
Q4 2021$596,000
-19.6%
43,740
-3.3%
0.22%
-24.1%
Q3 2021$741,000
+71.5%
45,233
+76.3%
0.29%
+78.5%
Q2 2021$432,000
-56.4%
25,661
-52.7%
0.16%
-58.6%
Q1 2021$991,000
-11.8%
54,298
-12.0%
0.39%
-17.1%
Q4 2020$1,123,000
+29.7%
61,683
+27.1%
0.48%
+13.4%
Q3 2020$866,000
-9.5%
48,526
-9.1%
0.42%
-5.6%
Q2 2020$957,000
-7.7%
53,399
-21.8%
0.44%
-19.7%
Q1 2020$1,037,000
-26.2%
68,290
-4.2%
0.55%
-15.7%
Q4 2019$1,406,000
+8.7%
71,247
-5.3%
0.66%
-4.5%
Q3 2019$1,294,000
+15.1%
75,207
+18.5%
0.69%
+15.1%
Q2 2019$1,124,000
-6.5%
63,483
+7.6%
0.60%
-10.6%
Q1 2019$1,202,000
+33.6%
59,003
+10.3%
0.67%
+55.0%
Q4 2018$900,00053,5110.43%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders